Lumira Ventures

Activity from announced rounds

Activity in this selectionnomura-real-estate-development-co-f095adde
Rounds participated in
5
Confirmed lead rounds
0
4 roles undisclosed
New companies
5
First participation on record · 0 follow-on
Funding in participating rounds
$219.5M
5 disclosed · full round size, not this investor’s share

By stage

Series B3
Growth1
Series A1

By primary sector

Healthtech3
Biotech2

By country

Canada3
United States2

Rounds

5 in this selection
Altis Labs

AI software that uses clinical-trial imaging to measure treatment response and predict patient outcomes.

$25MSeries A
Participant
Contraline

Develops hormonal and non-hormonal male contraceptives for men and couples globally

$92.5MSeries B
Role not disclosed
Nervonik

Develops peripheral nerve stimulation technologies for chronic pain and neurological conditions

$52.5MSeries B
Role not disclosed
Exact Imaging

Develops high-resolution micro-ultrasound systems for urologic imaging

$10MGrowth
Role not disclosed